SCHEMBL5110110

SCHEMBL5110110

CCC(=O)Nc1cccc(COc2c(Cl)cc(CC(=O)O)cc2Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A2 P43004 1/20 0.51
SLC1A1 P43005 1/20 0.51
THRA P10827 2/20 0.51
THRB P10828 2/20 0.51
SENP5 Q96HI0 1/20 0.51
SENP2 Q9HC62 1/20 0.51
SENP1 Q9P0U3 1/20 0.51
SELP P16109 2/20 0.49
SELE P16581 2/20 0.49
GAA P10253 2/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
MRGPRX4 Q96LA9 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
RAB9A P51151 3/20 0.45
POLB P06746 1/20 0.45
NR4A1 P22736 1/20 0.45
CYP3A4 P08684 1/20 0.45
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722815 0.90 SENP1 (0.48) SLC1A2SLC1A1THRATHRBSENP5
SCHEMBL4354909 0.89 THRA (0.61) SLC1A2SLC1A1THRATHRBSENP5
SCHEMBL5110363 0.89 THRB (0.60) SLC1A2SLC1A1THRATHRBSENP5
SCHEMBL5111290 0.88 CLCN2 (0.52) THRATHRBSENP5SENP2SENP1
SCHEMBL4932778 0.86 THRB (0.62) THRATHRBSENP5SENP2SENP1
SCHEMBL5109827 0.86 THRB (0.50) THRATHRBSENP5SENP2SENP1
SCHEMBL4929427 0.86 THRA (0.47) THRATHRBSELPSELEMRGPRX4
SCHEMBL5104534 0.85 THRA (0.52) THRATHRBSENP5SENP2SENP1
SCHEMBL5117132 0.85 THRB (0.49) THRATHRBSENP5SENP2SENP1
SCHEMBL5117798 0.84 THRB (0.48) THRATHRBSENP5SENP2SENP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA SLC1A2 2235/4885SLC1A1 1478/4885THRA 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.